David-Alexandre C. Gros
Board Member
Eledon Pharmaceuticals, Inc. (ELDN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David-Alexandre C. Gros
David-Alexandre C. Gros is recorded as CEO and Board Member at Eledon Pharmaceuticals, Inc. (ELDN). Eledon Pharmaceuticals, Inc. reported in an 8-K filed June 22, 2023 that David-Alexandre C. Gros was appointed Class III Director, effective June 21, 2023. The proxy statement of Eledon Pharmaceuticals, Inc. reports total compensation of $3,216,148 for David-Alexandre C. Gros in fiscal 2025, including a base salary of $613,196. Disclosed compensation is on record for 6 fiscal years.
“The stockholders of the Company elected each of David-Alexandre C. Gros, M.D. and Jan Hillson, M.D. as Class III Directors for a three-year term ending at the Annual Meeting of Stockholders to be held in 2026 and until each of their successors has been duly elected and qualified, or until their earlier death, resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-06-21–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Eledon Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- David-Alexandre "DA" C. Gros, M.D. CEO, Board Member
- David-Alexandre C. Gros, M.D. CEO, Board Member
- David-Alexandre Gros CEO, Board Member
- Jon Kuwahara CEO
- Paul Little CFO, Chief Accounting Officer
- Bryan Smith General Counsel
- Allan D. Kirk Board Member
- Allan Douglas Kirk, MD, PhD, FACS Board Member
- James Robinson Board Member
- Jan Hillson Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Eledon Pharmaceuticals, Inc. (ELDN) | Chief Executive Officer | $613,196 | $3,216,148 |
| 2024 | Eledon Pharmaceuticals, Inc. (ELDN) | Chief Executive Officer | $582,269 | $5,644,970 |
| 2023 | Eledon Pharmaceuticals, Inc. (ELDN) | Chief Executive Officer | $559,478 | $2,553,153 |
| 2022 | Eledon Pharmaceuticals, Inc. (ELDN) | Chief Executive Officer | $532,503 | $1,118,493 |
| 2021 | Eledon Pharmaceuticals, Inc. (ELDN) | Chief Executive Officer | $503,654 | $747,504 |
| 2020 | Eledon Pharmaceuticals, Inc. (ELDN) | Chief Executive Officer | $150,000 | $7,419,307 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.